Joint association of atherogenic index of plasma and estimated glucose disposal rate with new-onset cardiovascular disease risk in individuals with cardiovascular-kidney-metabolic syndrome stages 0-3: a 9-year nationwide prospective cohort study

Cardiovasc Diabetol. 2026 May 2. doi: 10.1186/s12933-026-03200-5. Online ahead of print.ABSTRACTBACKGROUND: The atherogenic index of plasma (AIP) and estimated glucose disposal rate (eGDR) are two composite indices derived from routine metabolic measurements and are associated with cardiocerebrovasc

Y Yuhang Fan

Lipid levels and risk-stratified management gaps of dyslipidemia in China

BMC Med. 2026 May 2. doi: 10.1186/s12916-026-04904-x. Online ahead of print.ABSTRACTBACKGROUND: Dyslipidemia remains a major modifiable contributor to China's cardiovascular disease (CVD) burden, yet large-scale evidence on risk-stratified management gaps is lacking.METHODS: In this nationwide study

L Long Zhang

Nanomedicine-based theranostics in atherosclerotic cardiovascular diseases

J Biomed Sci. 2026 May 2;33(1):43. doi: 10.1186/s12929-026-01245-y.ABSTRACTCurrent treatment for atherosclerotic cardiovascular diseases (ASCVD) mainly focuses on the modification of systemic risk factors, such as hyperglycemia and hyperlipidemia. Despite significant efforts and expanse, achieving e

C Chih-Fan Yeh